{"abstract": "Just hours after announcing its $8.4 billion acquisition of Cubist Pharmaceuticals, a Delaware judge invalidated patents owned by the antibiotics maker. Merck appears to have been caught up in the M.&.A. exuberance, says Robert Cyran of Reuters Breakingviews.", "web_url": "https://dealbook.nytimes.com/2014/12/09/mercks-rose-colored-deal-making/", "snippet": "Just hours after announcing its $8.4 billion acquisition of Cubist Pharmaceuticals, a Delaware judge invalidated patents owned by the antibiotics maker. Merck appears to have been caught up in the M.&.A. exuberance, says Robert Cyran of Reuters Br...", "lead_paragraph": "The M.&A. frenzy appears to have influenced Merck\u2019s risk assessment. Just hours after announcing its $8.4 billion acquisition of Cubist Pharmaceuticals on Monday, a judge invalidated patents owned by the antibiotics maker. Potential lost sales are reflected in the billions erased from Merck\u2019s market value.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Merck\u2019s Rose-Colored Glasses in Cubist Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "ANTIBIOTICS", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Inventions and Patents", "rank": 3, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Cubist Pharmaceuticals Inc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 7, "major": "N"}], "pub_date": "2014-12-09T19:30:42+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Robert Cyran", "person": [{"firstname": "Robert", "middlename": null, "lastname": "Cyran", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d5fe4dae-9f6a-5f97-ad57-f29e4c91ba68", "word_count": 369, "uri": "nyt://article/d5fe4dae-9f6a-5f97-ad57-f29e4c91ba68"}